logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Noninvasive in vivo photoacoustic detection of malaria with Cytophone in Cameroon

Yadem AC, Armstrong JN, Sarimollaoglu M, Kiki Massa C, Ndifo JM,  et al.
2024-10-25 • Nature Communications
2024-10-25 • Nature Communications

Current malaria diagnostics are invasive, lack sensitivity, and rapid tests are plagued by deletions in tar...

Journal Article
|
Research

Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis

Kho S, Seung KJ, Huerga H, Bastard M, Khan PY,  et al.
2024-05-09 • Nature Communications
2024-05-09 • Nature Communications
Sputum culture reversion after conversion is an indicator of tuberculosis (TB) treatment failure. We analyze data from the endTB multi-country prospective observational cohort (NCT032592...
Journal Article
|
Research

AI-based mobile application to fight antibiotic resistance

Pascucci M, Royer G, Adamek J, Al Asmar M, Aristizabal D,  et al.
2021-02-19 • Nature Communications
2021-02-19 • Nature Communications
Antimicrobial resistance is a major global health threat and its development is promoted by antibiotic misuse. While disk diffusion antibiotic susceptibility testing (AST, also called an...
Journal Article
|
Research

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment

Cross RW, Bornholdt ZA, Prasad AN, Geisbert JB, Borisevich V,  et al.
2020-07-27 • Nature Communications
2020-07-27 • Nature Communications
A replication-competent vesicular stomatitis virus vaccine expressing the Ebola virus (EBOV) glycoprotein (GP) (rVSV-ZEBOV) was successfully used during the 2013-16 EBOV epidemic. Additi...